Cipla rises on the bourses

24 Feb 2025 Evaluate

Cipla is currently trading at Rs. 1475.50, up by 1.20 points or 0.08% from its previous closing of Rs. 1474.30 on the BSE.

The scrip opened at Rs. 1468.55 and has touched a high and low of Rs. 1488.00 and Rs. 1459.15 respectively. So far 11029 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 1702.00 on 09-Oct-2024 and a 52 week low of Rs. 1317.60 on 10-May-2024.

Last one week high and low of the scrip stood at Rs. 1501.05 and Rs. 1422.75 respectively. The current market cap of the company is Rs. 119276.65 crore.

The promoters holding in the company stood at 29.19%, while Institutions and Non-Institutions held 54.28% and 16.52% respectively.

Cipla has received final approval from the United States Food and Drug Administration (USFDA) for the New Drug Application (NDA) submitted for ‘Nilotinib Capsules 50, 150 and 200 mg’ on February 19, 2025.

Nilotinib is an oncology category product in capsule form for oral consumption and is used for treatment of philadelphia chromosome positive chronic myeloid leukemia (CML). The product is expected to be launched in FY 2025-26 in the United States of America.

Cipla is a global pharmaceutical company which uses cutting edge technology and innovation to meet the everyday needs of all patients.

Cipla Share Price

1452.70 8.15 (0.56%)
02-Apr-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1714.25
Dr. Reddys Lab 1149.75
Cipla 1452.70
Lupin 2009.40
Zydus Lifesciences 891.25
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
Please wait your portfolio is updating...